![](https://cdn.snapi.dev/images/v1/y/d/biotech8-827380.jpg)
News for ImmunityBio Stock (IBRX)
![](https://cdn.snapi.dev/images/v1/y/d/biotech8-827380.jpg)
![](https://cdn.snapi.dev/images/v1/n/t/biotech3-827276.jpg)
![](https://cdn.snapi.dev/images/v1/j/t/press2-826805.jpg)
InvestorPlace •
![](https://cdn.snapi.dev/images/v1/k/q/biotech7-817390.jpg)
Zacks Investment Research •
![](https://cdn.snapi.dev/images/v1/c/z/stocks-market-11-760284-803339.jpg)
![](https://cdn.snapi.dev/images/v1/b/y/press2-801949.jpg)
Business Wire •
![](https://cdn.snapi.dev/images/v1/e/g/press6-793239.jpg)
Business Wire •
![](https://cdn.snapi.dev/images/v1/d/3/press7-779511.jpg)
![](https://cdn.snapi.dev/images/v1/o/r/biotech16-771013.jpg)
Zacks Investment Research •
![](https://cdn.snapi.dev/images/v1/0/0/biotech37-760095.jpg)
![](https://cdn.snapi.dev/images/v1/a/c/biotech2-757807.jpg)
![](https://cdn.snapi.dev/images/v1/9/o/press4-757419.jpg)
![](https://cdn.snapi.dev/images/v1/k/f/press3-748936.jpg)
ImmunityBio's Prostate Cancer Vaccine Shows Early Signs Of Clinical Activity, Durable Stable Disease
Benzinga •
![](https://cdn.snapi.dev/images/v1/1/d/biotech25-743201.jpg)
![](https://cdn.snapi.dev/images/v1/s/y/press19-742923.jpg)
![](https://cdn.snapi.dev/images/v1/m/f/press13-733446.jpg)